Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-038/00
A61F-002/04
출원번호
UP-0649935
(2007-01-05)
등록번호
US-7531505
(2009-07-01)
발명자
/ 주소
Hamilton, Paul Theodore
Kenan, Daniel James
Solan, Amy Katherine
출원인 / 주소
Affinergy, Inc.
대리인 / 주소
Kiefer, Laura L.
인용정보
피인용 횟수 :
2인용 특허 :
15
초록▼
The present invention provides compositions and methods for an improved coating for medical devices. Provided is a biofunctional coating composition comprising at least one binding domain that has binding specificity for a metallic surface material of a medical device, and at least one binding domai
The present invention provides compositions and methods for an improved coating for medical devices. Provided is a biofunctional coating composition comprising at least one binding domain that has binding specificity for a metallic surface material of a medical device, and at least one binding domain that has binding specificity for cells of endothelial cell lineage. Methods for coating a metallic surface of a medical device, and for manufacturing of a medical device, comprise contacting the metallic surface to be coated with the biofunctional coating material in an amount effective to form a coating, and may further comprise contacting the coated surface with cells of endothelial cell lineage to bind the cells of endothelial cell lineage to the coated surface.
대표청구항▼
What is claimed is: 1. A biofunctional coating composition comprising at least one binding domain that specifically binds to a metallic surface material of a medical device ("surface-binding domain"), and at least one binding domain that specifically binds to cells of endothelial cell lineage ("end
What is claimed is: 1. A biofunctional coating composition comprising at least one binding domain that specifically binds to a metallic surface material of a medical device ("surface-binding domain"), and at least one binding domain that specifically binds to cells of endothelial cell lineage ("endothelial-binding domain"); wherein the surface-binding domain comprises a peptide having a length of 16 to 60 amino acids comprising SEQ ID NO:5, and wherein the peptide can be modified to comprise one or more terminal modifications, and a modification to facilitate linking; wherein the endothelial-binding domain comprises a peptide having a length of 18 to 60 amino acids comprising SEQ ID NO:19; and wherein the peptide can be modified to comprise one or more terminal modifications, and a modification to facilitate linking, or one or more conservative substitutions in SEQ ID NO:19, and wherein the surface-binding domain is coupled to the endothelial-binding domain. 2. The biofunctional coating composition according to claim 1, wherein the endothelial-binding domain is bound to cells of endothelial cell lineage. 3. The biofunctional coating composition according to claim 1, wherein the biofunctional coating composition comprises more than one endothelial-binding domain. 4. The biofunctional coating composition according to claim 1, wherein the cells of endothelial cell lineage, for which the endothelial-binding domain has binding specificity, comprise cells selected from the group consisting of endothelial cells, endothelial progenitor cells, and a combination thereof. 5. The biofunctional coating composition according to claim 1, wherein the biofunctional coating composition comprises more than one surface-binding domain. 6. The biofunctional coating composition according to claim 1, wherein the metallic surface material, for which the surface-binding domain has binding specificity, comprises a material selected from the group consisting of a metal, a metal oxide, a metal alloy, and a combination thereof. 7. The biofunctional coating composition according to claim 1, wherein the metallic surface material, for which the surface-binding domain has binding specificity, comprises stainless steel. 8. The biofunctional coating composition according to claim 1, wherein the surface binding domain comprises a multimer of the peptide. 9. The biofunctional coating composition according to claim 1, wherein the surface-binding domain and the endothelial-binding domain are coupled together via a linker. 10. An endothelial-binding domain comprising a peptide having a length of 18 to 60 amino acids comprising SEQ ID NO:19 and wherein the peptide can be modified to comprise one or more terminal modifications, and a modification to facilitate linking, or one or more conservative substitutions in SEQ ID NO:19. 11. A surface-binding domain comprising a peptide having a length of 16 to 60 amino acids comprising SEQ ID NO:5, and wherein the peptide can be modified to comprise one or more terminal modifications, and a modification to facilitate linking. 12. The surface-binding domain according to claim 11, wherein the surface-binding domain comprises a multimer of the peptide. 13. The biofunctional coating composition according to claim 1, wherein the surface-binding domain comprises SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, or SEQ ID NO:8. 14. A method for coating at least one metallic surface of a medical device, the method comprising contacting the at least one metallic surface of the medical device with a biofunctional coating composition according to claim 1 to form a coating on the at least one surface; and wherein the endothelial-binding domain is in an amount effective for adhering cells of endothelial cell lineage to the coating on the at least one metallic surface. 15. The method according to claim 14, wherein the medical device comprises a vascular device. 16. The method according to claim 15, wherein the vascular device comprises a stent. 17. The method according to claim 14, wherein the surface-binding domain and the endothelial-binding domain are coupled via a linker. 18. The method according to claim 14, wherein the surface-binding domain comprises a multimer of the peptide. 19. The method according to claim 14, wherein endothelial-binding domain is bound to cells of endothelial cell lineage. 20. The method according to claim 14, wherein the biofunctional coating composition comprises more than one endothelial-binding domain. 21. The method according to claim 14, wherein the biofunctional coating composition comprises more than one surface-binding domain. 22. The method according to claim 14, wherein the surface-binding domain has an amino acid sequence of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, or SEQ ID NO:8.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (15)
Udayan G. Patel ; Richard S. Stack, Composite intraluminal prostheses.
Brasile Lauren (61 Meadow La. Albany NY 12208), Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.